2015 Leads Side effects 
World of DTC Marketing
JUNE 27, 2021
Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? Wegovy’s most common side effects were gastrointestinal problems, including nausea, diarrhea, and vomiting, which 80% of patients reported, according to USA Today.
World of DTC Marketing
MARCH 19, 2021
There are many reasons why people don’t take their medications, including cost and medication side effects but that’s only part of the picture. Plus, estimates are that nonadherence leads to up to 10% of hospitalizations and an estimated 125,000 deaths annually. Americans are not healthy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 7, 2022
This is especially beneficial as a way of decreasing potential side effects. In the years 2015 and 2020, clinical-stage cancer programmes increased by a considerable 77 percent (1,642 to 2,911), resulting in a quarter of drugs currently in development worldwide being highly potent.
Pharmaceutical Technology
AUGUST 26, 2022
This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. As patients with a drug-resistant form of TB cannot receive the standard regimen, their treatment courses tend to be more complex and often cause unsavoury side effects.
PM360
AUGUST 26, 2024
Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells). Let’s take cancer for example.
European Pharmaceutical Review
JULY 5, 2022
There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. 2015; 35(3):1437-45.
European Pharmaceutical Review
DECEMBER 14, 2023
They enable a range of observational study designs to be used where researchers study a period of exposure to a particular medicine and compare it with a control period of non-exposure in the same patient to establish any changes in the risk of adverse side effects. EMA/95098/2010. Internet] European Medicines Agency. cited Dec2023].
Expert insights. Personalized for you.
194 
Let's personalize your content